tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Rigel Pharmaceuticals Inc

RIGL
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
36.815USD
-1.245-3.27%
์ข…๊ฐ€ย 07-31 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
667.97M์‹œ๊ฐ€์ด์•ก
1.82P/E TTM

RIGL ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Rigel Pharmaceuticals Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Rigel Pharmaceuticals Inc ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
Aug 4, 2026
EPS / ์˜ˆ์ƒ
--/0.62
์ˆ˜์ต / ์˜ˆ์ƒ
--/69.46M
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
294.28M
64.15%
EPS(YoY)
20.40
1951.47%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/07/31
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-26.87%0.47
1711.34%14.72
119.16%1.55
5779.21%3.33
236.55%0.64
1821.06%0.81
316.22%0.71
84.55%-0.06
39.65%-0.47
-57.70%0.04
---0.33
---0.38
---0.78
--0.10
---3.48
----
----
----
----
----
์ˆ˜์ต
10.28%58.82M
21.19%69.80M
25.59%69.46M
176.01%101.69M
80.58%53.33M
60.92%57.60M
96.58%55.31M
37.03%36.84M
13.29%29.53M
-30.20%35.79M
25.54%28.13M
-9.84%26.89M
55.78%26.07M
151.25%51.28M
4.02%22.41M
13.53%29.82M
-79.34%16.73M
10.62%20.41M
17.15%21.54M
63.95%26.27M
์ˆœ์ด์ต
-24.39%8.65M
1769.22%268.06M
124.62%27.90M
5887.67%59.61M
238.79%11.45M
1845.86%14.34M
318.22%12.42M
84.39%-1.03M
39.07%-8.25M
-47.39%737.00K
70.10%-5.69M
51.08%-6.60M
50.68%-13.54M
106.19%1.40M
9.14%-19.04M
2.38%-13.49M
-169.48%-27.45M
-17.70%-22.64M
-47.82%-20.95M
21.36%-13.82M
์ˆœ์ด์ต๋ฅ 
-31.44%14.71%
1442.36%384.04%
78.85%40.17%
2196.90%58.63%
176.86%21.46%
1109.22%24.90%
211.01%22.46%
88.61%-2.80%
46.22%-27.92%
-24.63%2.06%
---20.23%
---24.55%
---51.92%
--2.73%
---86.96%
----
----
----
----
----
์ด ์ด์ต๋ฅ 
0.48%92.17%
1.69%91.47%
8.97%93.16%
3.45%95.57%
-1.51%91.73%
0.60%89.95%
-10.48%85.49%
-3.77%92.38%
-3.23%93.14%
-9.99%89.41%
--95.49%
--96.00%
--96.25%
--99.33%
--97.96%
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
-73.82%8.89%
-72.02%10.18%
-42.55%24.63%
-37.76%28.93%
-28.04%33.95%
-28.42%36.40%
-17.14%42.87%
-8.63%46.49%
-1.96%47.18%
73.07%50.84%
--51.73%
--50.88%
--48.12%
--29.38%
--34.14%
----
----
----
----
----
์ˆ˜์ต
10.28%58.82M
21.19%69.80M
25.59%69.46M
176.01%101.69M
80.58%53.33M
60.92%57.60M
96.58%55.31M
37.03%36.84M
13.29%29.53M
-30.20%35.79M
25.54%28.13M
-9.84%26.89M
55.78%26.07M
151.25%51.28M
4.02%22.41M
13.53%29.82M
-79.34%16.73M
10.62%20.41M
17.15%21.54M
63.95%26.27M
์˜์—… ์ด์ต
-6.95%11.88M
39.12%23.17M
102.19%28.42M
13569.57%61.10M
283.36%12.77M
747.15%16.66M
414.80%14.06M
108.49%447.00K
45.26%-6.97M
-42.16%1.97M
75.74%-4.46M
59.38%-5.27M
51.54%-12.72M
118.99%3.40M
6.99%-18.40M
0.64%-12.96M
-162.89%-26.26M
4.94%-17.90M
-43.57%-19.79M
24.98%-13.05M
์ˆœ์ด์ต
-24.39%8.65M
1769.22%268.06M
124.62%27.90M
5887.67%59.61M
238.79%11.45M
1845.86%14.34M
318.22%12.42M
84.39%-1.03M
39.07%-8.25M
-47.39%737.00K
70.10%-5.69M
51.08%-6.60M
50.68%-13.54M
106.19%1.40M
9.14%-19.04M
2.38%-13.49M
-169.48%-27.45M
-17.70%-22.64M
-47.82%-20.95M
21.36%-13.82M
์œ ๋™์ž์‚ฐ
59.68%234.03M
77.77%240.17M
101.87%214.93M
85.16%175.39M
58.47%146.56M
36.10%135.10M
12.04%106.47M
-6.15%94.72M
-13.54%92.49M
-14.35%99.27M
-13.96%95.02M
-16.26%100.92M
-23.01%106.97M
-24.97%115.90M
-35.45%110.44M
-34.57%120.52M
-29.39%138.94M
73.59%154.47M
71.36%171.10M
62.88%184.20M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
34.31%89.49M
56.77%99.24M
73.81%94.40M
47.72%86.64M
-8.97%66.63M
18.83%63.30M
12.51%54.31M
33.22%58.65M
60.81%73.20M
-18.32%53.27M
2.13%48.27M
-19.89%44.02M
-23.14%45.52M
2.61%65.21M
-20.27%47.27M
-7.71%54.95M
13.85%59.23M
55.61%63.55M
73.38%59.28M
71.30%59.54M
์ด ์ž์‚ฐ
186.75%504.61M
213.21%513.59M
73.96%242.53M
61.00%206.74M
39.09%175.97M
39.88%163.98M
20.89%139.42M
9.67%128.41M
2.35%126.52M
-12.70%117.22M
-0.25%115.32M
-8.52%117.09M
-17.08%123.61M
-19.75%134.28M
-38.02%115.61M
-36.51%128.00M
-30.98%149.07M
51.60%167.33M
51.57%186.52M
46.05%201.60M
๋ถ€์ฑ„ ์ด๊ณ„
-33.48%104.71M
-24.01%122.11M
-18.91%124.92M
-21.17%124.80M
-0.50%157.41M
10.16%160.69M
4.69%154.06M
9.03%158.32M
6.98%158.19M
-1.37%145.87M
8.65%147.16M
10.27%145.21M
3.93%147.87M
7.99%147.90M
-1.03%135.44M
-1.36%131.68M
3.33%142.28M
79.37%136.95M
89.80%136.85M
78.40%133.49M
์ž๋ณธ ์ด๊ณ„
2053.81%399.90M
11806.33%391.48M
903.56%117.61M
373.90%81.93M
158.62%18.57M
111.48%3.29M
54.02%-14.64M
-6.40%-29.91M
-30.56%-31.67M
-110.37%-28.64M
-60.50%-31.83M
-664.62%-28.11M
-456.83%-24.26M
-144.83%-13.62M
-139.93%-19.83M
-105.40%-3.68M
-91.32%6.80M
-10.73%30.37M
-2.52%49.67M
7.75%68.11M
์ˆœ์˜์—…์ด์ต
405.15%2.73M
51.55%21.98M
10.85%24.03M
10011.59%30.54M
82.19%-893.00K
332.42%14.50M
1695.22%21.68M
-94.91%302.00K
-23.05%-5.01M
71.52%-6.24M
89.78%-1.36M
145.93%5.93M
84.11%-4.07M
-14.79%-21.91M
-29.17%-13.30M
-123.38%-12.91M
-28.47%-25.64M
-22.57%-19.09M
47.15%-10.30M
493.33%55.22M
์ˆœํˆฌ์ž
24.42%-7.97M
-132.38%-25.36M
-972.57%-33.17M
-312.97%-23.28M
-3471.25%-10.55M
-58.77%-10.91M
424.96%3.80M
267.98%10.93M
-59.72%313.00K
-136.96%-6.87M
-111.19%-1.17M
-85.92%2.97M
-96.57%777.00K
186.65%18.60M
123.55%10.46M
142.48%21.09M
200.44%22.63M
-25.52%6.49M
-327.35%-44.40M
-848.78%-49.66M
์ˆœ์žฌ๋ฌดํ™œ๋™
-2355.99%-10.92M
-412.08%-4.57M
143.40%4.27M
155.59%418.00K
119.27%484.00K
201.44%1.47M
-1032.57%-9.84M
-101.61%-752.00K
-113.14%-2.51M
123.19%486.00K
-115.77%-869.00K
93.41%-373.00K
117.38%19.12M
-293.18%-2.10M
1911.31%5.51M
-109.56%-5.66M
319.50%8.80M
62.67%1.08M
426.92%274.00K
463.13%59.22M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Rigel Pharmaceuticals Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Rigel Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 294.28M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 179.28M์ž…๋‹ˆ๋‹ค.

Rigel Pharmaceuticals Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Rigel Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 240.17M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 77.77์ž…๋‹ˆ๋‹ค.

Rigel Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Rigel Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Rigel Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ 513.59M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 213.21์ž…๋‹ˆ๋‹ค.

Rigel Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Rigel Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Rigel Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” 122.11M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -24.01์ž…๋‹ˆ๋‹ค.

Rigel Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Rigel Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Rigel Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ 391.48M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 11806.33์ž…๋‹ˆ๋‹ค.

Rigel Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Rigel Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Rigel Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ 125.47M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 418.63์ž…๋‹ˆ๋‹ค.

Rigel Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Rigel Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Rigel Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” -92.36M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -2336.44์ž…๋‹ˆ๋‹ค.

Rigel Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Rigel Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Rigel Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 601.00K์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 105.16์ž…๋‹ˆ๋‹ค.

Rigel Pharmaceuticals Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Rigel Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ 20.40์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 1951.47์ž…๋‹ˆ๋‹ค.

Rigel Pharmaceuticals Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Rigel Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ 367.02M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 1999.08์ž…๋‹ˆ๋‹ค.

Rigel Pharmaceuticals Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Rigel Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ 124.72์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 1178.77์ž…๋‹ˆ๋‹ค.

Rigel Pharmaceuticals Inc์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Rigel Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 93.33์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 4.17์ž…๋‹ˆ๋‹ค.

Rigel Pharmaceuticals Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Rigel Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 10.18์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -72.02์ž…๋‹ˆ๋‹ค.

Rigel Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Rigel Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ 108.34์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 771.15์ž…๋‹ˆ๋‹ค.

Rigel Pharmaceuticals Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Rigel Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ 125.47M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 418.63์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ